161 related articles for article (PubMed ID: 17579254)
1. A lack of synergistic interaction between insulin and pioglitazone on reactivity of rat aorta from chronically high dose insulin-treated diabetic rats.
Sahilli M; Irat AM; Işik AC; Karasu C; Ozansoy G; Ari N
Gen Physiol Biophys; 2007 Mar; 26(1):48-55. PubMed ID: 17579254
[TBL] [Abstract][Full Text] [Related]
2. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
[TBL] [Abstract][Full Text] [Related]
3. Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.
Abbasi F; Lima NK; Reaven GM
Metabolism; 2009 Mar; 58(3):373-8. PubMed ID: 19217454
[TBL] [Abstract][Full Text] [Related]
4. Alteration of vascular reactivity in diabetic human mammary artery and the effects of thiazolidinediones.
Irat AM; Aslamaci S; Karasu C; Ari N
J Pharm Pharmacol; 2006 Dec; 58(12):1647-53. PubMed ID: 17331329
[TBL] [Abstract][Full Text] [Related]
5. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
6. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
Toba H; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Murakami M; Morita Y; Nakayama Y; Kobara M; Nakata T
Eur J Pharmacol; 2006 Nov; 549(1-3):124-32. PubMed ID: 16979161
[TBL] [Abstract][Full Text] [Related]
7. A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues.
Elçioğlu HK; Kabasakal L; Özkan N; Çelikel Ç; Ayanoğlu-Dülger G
Eur J Pharmacol; 2011 Jun; 660(2-3):476-84. PubMed ID: 21463620
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
Shen X; Li H; Li W; Wu X; Ding X
Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
[TBL] [Abstract][Full Text] [Related]
9. Effects of administration of oral magnesium on plasma glucose and pathological changes in the aorta and pancreas of diabetic rats.
Soltani N; Keshavarz M; Minaii B; Mirershadi F; Zahedi Asl S; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):604-10. PubMed ID: 16120185
[TBL] [Abstract][Full Text] [Related]
10. Effects of pioglitazone and rosiglitazone on aortic vascular function in rat genetic hypertension.
Llorens S; Mendizabal Y; Nava E
Eur J Pharmacol; 2007 Dec; 575(1-3):105-12. PubMed ID: 17803988
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones and blood lipids in type 2 diabetes.
van Wijk JP; de Koning EJ; Martens EP; Rabelink TJ
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1744-9. PubMed ID: 12907465
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone, a PPAR-gamma ligand inhibited the nicotinamide-streptozotocin induced sperm abnormalities in type-2 diabetic Wistar rats.
Rabbani SI; Devi K; Khanam S
Pak J Pharm Sci; 2010 Jul; 23(3):326-31. PubMed ID: 20566448
[TBL] [Abstract][Full Text] [Related]
13. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
Matsuura B; Kanno S; Minami H; Tsubouchi E; Iwai M; Matsui H; Horiike N; Onji M
J Gastroenterol; 2004; 39(4):339-45. PubMed ID: 15168245
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the mechanisms of insulin vasodilatation of normal and streptozotocin-induced diabetic rat aorta.
Subramaniam G; Achike FI; Mustafa MR
J Cardiovasc Pharmacol; 2009 Apr; 53(4):333-40. PubMed ID: 19295443
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
17. IGF-I-induced enhancement of contractile response in organ-cultured aortae from diabetic rats is mediated by sustained thromboxane A2 release from endothelial cells.
Kobayashi T; Matsumoto T; Kamata K
J Endocrinol; 2005 Aug; 186(2):367-76. PubMed ID: 16079262
[TBL] [Abstract][Full Text] [Related]
18. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Gaikwad AB; Viswanad B; Ramarao P
Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity.
El-Bassossy HM; Abo-Warda SM; Fahmy A
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):643-9. PubMed ID: 22594672
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic and antihyperglycemic effect of Begonia malabarica Lam. in normal and streptozotocin induced diabetic rats.
Pandikumar P; Babu NP; Ignacimuthu S
J Ethnopharmacol; 2009 Jul; 124(1):111-5. PubMed ID: 19443148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
